+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report by Type, Application, Distribution Channel, Region, and Segment Forecasts, 2026-2033 - Product Thumbnail Image

Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report by Type, Application, Distribution Channel, Region, and Segment Forecasts, 2026-2033

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Ulcerative Colitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Ulcerative Colitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 130 Pages
  • Global
From
Ursodeoxycholic Acid Drugs for Hepatobiliary Diseases Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ursodeoxycholic Acid Drugs for Hepatobiliary Diseases Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Turkey Generic Drugs Market Competition Forecast and Opportunities, 2028 - Product Thumbnail Image

Turkey Generic Drugs Market Competition Forecast and Opportunities, 2028

  • Report
  • August 2023
  • 76 Pages
  • Turkey
From
Bacterial Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Bacterial Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Leukemia Cancer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Leukemia Cancer Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 102 Pages
  • Global
From
Analgesics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Analgesics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • March 2024
  • 210 Pages
  • Global
From
Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2026-2034 - Product Thumbnail Image

Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2026-2034

  • Report
  • April 2026
  • 148 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • October 2026
  • 196 Pages
  • Global
From
Gynecological Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecological Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 193 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • October 2026
  • 246 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • October 2026
  • 190 Pages
  • Global
From
Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • October 2026
  • 175 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 193 Pages
  • Global
From
Neuroendocrine Tumor Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumor Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 383 Pages
  • Global
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 126 Pages
  • Global
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 188 Pages
  • Global
From
Loading Indicator